Month: April 2026
Trump’s address, SpaceX IPO, Sam’s Club membership prices and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Thursday. It’s the one-year anniversary of President Donald Trump’s initial tariff unveiling, what the president dubbed “liberation day.” Stock futures are falling this morning. The three major indexes are coming off another winning day. Here are five key things investors need […]
Read More
Trump’s Iran speech ignores the risks of a return to the 1970s: Analysis
Demonstrators hold posters of Ayatollah Khomeini outside the American Embassy which is occupied by ‘students following the Imam Khomeini’s line on November 16, 1979 in Tehran, Iran. Kaveh Kazemi | Hulton Archive | Getty Images “The hard part is done,” President Donald Trump said in his address to the nation Wednesday night about the Iran […]
Read More
Givers’ regret: What happens when wealthy parents try to claw back fortunes from their kids
Thomas Barwick | Digitalvision | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. While many wealthy parents are breathing a sigh of relief over estate tax changes in last […]
Read More
Stocks making the biggest moves premarket: Exxon Mobil, Carnival, Delta, General Motors and more
Check out the companies making the biggest moves in premarket trading: Oil stocks — Shares of energy companies jumped alongside the move higher in oil prices , which surged more than 7% after President Donald Trump’s speech Wednesday night indicated the war in Iran would continue. APA gained 4.3%, while Diamondback Energy , ConocoPhillips , […]
Read More
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly‘s rival pill that was approved this week, Novo Nordisk said Thursday. Oral Wegovy demonstrated “significantly greater mean weight loss” than orforglipron, which Lilly will sell under the […]
Read More
Thorne is on pace for $650 million in sales as Gen Z fuels a supplement boom — despite subscription fatigue
Supplement brand Thorne is on pace to reach $650 million in annual revenue this year, fueled by Gen Z and millennial shoppers who are increasingly focused on improving their health, CNBC has learned. The 42-year-old supplement brand, which L Catterton took private in 2023, has sustained a compound annual growth rate of over 30% since […]
Read More
Trump’s Iran timeline may not be short enough to avoid oil demand destruction
Vehicles have their gasoline tanks filled at a Costco Wholesale store on March 21, 2026, in Bayonne, New Jersey. Gary Hershorn | Corbis News | Getty Images U.S. President Donald Trump says he’ll end the war within weeks, but fears for oil supply and demand destruction are set to linger. In an address on Wednesday […]
Read More
Macquarie: India could emerge as an ‘AI powerhouse’ and names top stocks to watch
Despite being a global software powerhouse, India has been perceived as a laggard in the artificial intelligence space, with no current domestic chip industry or full-scale foundational AI model . But that narrative is set to change, according to Macquarie. The narrative of India as an AI bystander could shift to it being an “AI […]
Read More